Aktis Oncology is a biotechnology company focused on discovering and developing transformative therapies for solid cancers using alpha radiotherapy.

Aktis Oncology

Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. 

Bristol-Myers Squibb

EcoR1 Capital

Novartis

Octagon Capital Advisors

TCG Crossover

Vida Ventures

MPM Capital

Cowen Healthcare Investments

NS Investment

Merck

Mirae Asset Venture Investment

MRL Ventures Fund

Aktis Oncology is pleased to announce our participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. Matthew Roden, CEO, will be presenting on September 4th from 10:00 to 10:35 a.m. at the New York Marriott Marquis. 
  
We look forward to sharing our vision for the future of oncology and connecting with industry leaders and investors. 
 
https://lnkd.in/gxU8ZsCq

Today, we celebrate Women's Equality Day and honor the incredible contributions women have made to cancer research and treatment.
 
From Marie Curie's groundbreaking work on radioactivity to Dr. Jane Cooke Wright's pioneering chemotherapy research, women have been at the forefront of oncology breakthroughs for generations. 
 
At Aktis Oncology, we're proud to have talented women driving our mission forward. We remain committed to fostering an inclusive environment where all voices are heard and valued.

#WomensEqualityDay #WomeninSTEM #CancerResearch #JoinUs

At Aktis Oncology, we believe in supporting our community. On Child Protection Day, our team volunteered with GIVING FACTORY DIRECT by Cradles to Crayons to address clothing insecurity affecting 22 million American children.
 
Aktis Oncology proudly matched each donation. 
 
#ChildProtectionDay #GivingBack #cradlestocrayons

Today we are proud to announce the promotions of four exceptional people within our organization. Join us in congratulating:

·  Will Blackwell on his promotion to Director, Chemistry
·  Tatsiana Kosciuk on her promotion to Senior Scientist, Molecular Pharmacology
·  Marci Copeland on her promotion to Principal Scientist, Molecular Pharmacology
·  Wai Lau on his promotion to Director, Lead Discovery
 
We are proud to have such talented individuals as part of our team and look forward to their continued achievements in their new roles. Please join us in celebrating their well-deserved success!
 
#AktisOncology #GreatPlaceToWorkFor #GreatCompanyCulture #Collaboration #Innovation #Growth #Hiring

Celebrating PRIDE together!  
  
Our teams in Boston and RTP recently gathered for a special PRIDE luncheon. We proudly supported LGBTQ+ owned businesses, Basil Tree and Indulge Catering, who provided delicious food for the event. 
  
Thank you to all our employees who joined in this celebration. Together, we support an inclusive workplace for all. 
  
#PrideMonth #Inclusion #LGBTQAllies

In celebration of Asian America and Pacific Islander Heritage Month, we embraced the rich cultures of the Pacific Islands by offering hula lessons for our employees! 
  
It was amazing to see our team members learn the movements and meaningful traditions behind this beautiful Hawaiian dance. The lessons highlighted the storytelling and spiritual aspects of hula. Big mahalo to our Aktis hula instructor, Kelly Williamson Polanco, who was happy to share a part of her family heritage.
  
At Aktis Oncology, we take pride in recognizing the diverse backgrounds and perspectives of our team. Initiatives like this help create a more inclusive workplace where we can learn from each other and have fun. 
  
#AAPIHeritageMonth #DiversityCelebration #EmployeeEngagement #HulaDance

AKTI

COM:AKTISONCOLOGY

Aktis Oncology

name

homepage url

country

linkedin url

employee count

sector

industry

Description

investor of

Metrics